Drugs / Neuronox(R)
Neuronox(R)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03805152 Comparator | Oct 2019 → Jan 2021 | cervical dystonia | Department of Medical Services Ministry of Public Health of Thailand | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Neuronox(R) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03805152 ↗ |
| Known as | Meditoxin | “Neubotulinum Toxin Type A, (Neu-BoNT/A), (Neuronox® ) (Medytox Inc, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea), also known as Meditoxin in...” NCT03805152 ↗ |
| Known as | Neu-BoNT/A | “Neubotulinum Toxin Type A, (Neu-BoNT/A), (Neuronox® ) (Medytox Inc, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea), also known as Meditoxin in...” NCT03805152 ↗ |
| Known as | Neuronox | “Neubotulinum Toxin Type A, (Neu-BoNT/A), (Neuronox® ) (Medytox Inc, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea), also known as Meditoxin in...” NCT03805152 ↗ |
| Modality | Protein / enzyme biologic | “Neubotulinum Toxin Type A, (Neu-BoNT/A), (Neuronox® ) (Medytox Inc, Ochang-eup, Cheongwon-gu, Cheongju-si, Chungcheongbuk-do, Republic of Korea), also known as Meditoxin in...” NCT03805152 ↗ |
| Route | Intramuscular | “50 units Intramuscular injection” NCT03805152 ↗ |